Skip to main content
Fig. 7 | Cancer Communications

Fig. 7

From: Associations of PGK1 promoter hypomethylation and PGK1-mediated PDHK1 phosphorylation with cancer stage and prognosis: a TCGA pan-cancer analysis

Fig. 7

PGK1 pS203 and PDHK1 pT338 levels are associated with poor prognosis in cancer patients. K-Means cluster analysis was used to divide the indicated cancer patients into two groups with high and low levels of PGK1 pS203 and PDHK1 pT338. Kaplan–Meier survival curves were compared using the log-rank test. All statistical tests were two-sided. PGK1 pS203 phosphorylated phosphoglycerate kinase 1 (PGK1) S203, PDHK1 pT338 phosphorylated phosphorylate pyruvate dehydrogenase kinase 1 (PDHK1) T338, BRCA breast carcinoma, LIHC liver hepatocellular carcinoma, LUAD lung adenocarcinoma, STAD stomach adenocarcinoma, ESCA esophageal carcinoma

Back to article page